Description / Application
Imatinib methanesulfonate is a methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an anticoronaviral agent, an antineoplastic agent, a tyrosine kinase inhibitor and an apoptosis inducer. It contains an imatinib.
Identities
| Alternative Name | Imatinib methanesulfonate |
|---|---|
| Molecular Formula | C30H35N7O4S |
| Molecular Weight | 589.7 |
| MFCD | MFCD04307699 |
Safety
| Pictograms |
|
|---|---|
| Signal Word | Warning |
| Hazard Statements | H361 |
| Precautionary Statements | P264;P270;P301+P312;P330;P501 |